BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10561311)

  • 1. Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.
    Schirren AEC; Albrecht JD; Melchers S; Weiß C; Büttner S; Dippel E; Gosmann J; Jonak C; Klemke CD; Laturnus-Chang M; Livingstone E; Mitteldorf C; Schummer P; Stadler R; Stranzenbach R; Weyer-Fahlbusch SS; Wobser M; Ziemer M; Nicolay JP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):954-966. PubMed ID: 38279594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
    Quaglino P; Pimpinelli N; Zinzani PL; Paulli M; Pileri S; Berti E; Cerroni L; Guitart J; Kim YH; Rupoli S; Santucci M; Simontacchi G; Vermeer M; Hoppe R; Pro B; Swerdlow SH; Barosi G
    Hematol Oncol; 2024 Jan; 42(1):e3215. PubMed ID: 37649350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pulmonary diffuse large B-cell lymphoma in a young female patient.
    Kang DK; Kang MK; Heo W; Hwang YH
    Clin Case Rep; 2021 May; 9(5):e04102. PubMed ID: 34026145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review.
    Di Stefani A; Tagliaferri L; Lancellotta V; Fionda B; Fossati B; Balducci M; Federico F; Hohaus S; De Simone C; Gambacorta MA; Peris K
    Front Oncol; 2020; 10():1133. PubMed ID: 32760672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Literature Revision in Primary Cutaneous B-cell Lymphoma.
    Selva R; Violetti SA; Delfino C; Grandi V; Cicchelli S; Tomasini C; Fierro MT; Berti E; Pimpinelli N; Quaglino P
    Indian J Dermatol; 2017; 62(2):146-157. PubMed ID: 28400634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous lymphomas: diagnosis and treatment.
    Sokołowska-Wojdyło M; Olek-Hrab K; Ruckemann-Dziurdzińska K
    Postepy Dermatol Alergol; 2015 Oct; 32(5):368-83. PubMed ID: 26759546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.
    Orange M; Lace A; Fonseca MP; von Laue BH; Geider S; Kienle GS
    Glob Adv Health Med; 2012 Mar; 1(1):18-25. PubMed ID: 24278797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature.
    Ceovic R; Jovanovic I; Kostovic K; Rados J; Dotlic S; Radman I; Kulisic SM; Loncaric D
    Radiat Oncol; 2013 Jun; 8():147. PubMed ID: 23786884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic treatment of cutaneous lymphomas].
    Klemke CD
    Hautarzt; 2011 Jun; 62(6):436-43. PubMed ID: 21656114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous B-cell lymphoma. Classification and diagnostics].
    Geissinger E; Adam P; Müller-Hermelink HK; Rüdiger T
    Pathologe; 2007 Feb; 28(1):15-20. PubMed ID: 17195038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.
    Rijlaarsdam JU; Toonstra J; Meijer OW; Noordijk EM; Willemze R
    J Clin Oncol; 1996 Feb; 14(2):549-55. PubMed ID: 8636770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case].
    Grau E; Real E; Perella M; Escandon J; Pastor E; Gómez A
    Sangre (Barc); 1997 Jun; 42(3):231-3. PubMed ID: 9381268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
    de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
    Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
    Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
    J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.